Celularity received a formal notice from Nasdaq on June 9, 2026, regarding non-compliance with the minimum Market Value of Listed Securities (MVLS) requirement. The company failed to maintain the $35 million minimum market value threshold for 30 consecutive business days. Nasdaq has granted a 180-day grace period, expiring on December 7, 2026, to regain compliance. To regain compliance, the company must maintain a market value of at least $35 million for at least 10 consecutive business days before the deadline. The company is currently evaluating options to regain compliance, including potentially increasing stockholders' equity to at least $2.5 million.